Table 2.

Top 20 highly cited articles in the field of B cell and immunotherapy

Rank	Paper	DOI	Total citations	Total citations per year	Normalized total citations
1	HELMINK BA, 2020, NATURE	10.1038/s41586-019-1922-8	1219	243.8	26.7665604
2	CABRITA R, 2020, NATURE	10.1038/s41586-019-1914-8	1008	201.6	22.1334642
3	PETITPREZ F, 2020, NATURE	10.1038/s41586-019-1906-8	979	195.8	21.4966879
4	VINCENT J, 2010, CANCER RES	10.1158/0008-5472.CAN-09-3690	899	59.9333333	9.47645819
5	SUZUKI E, 2005, CLIN CANCER RES	10.1158/1078 − 0432.CCR-05-0883	815	40.75	8.52906977
6	LINNEMANN C, 2015, NAT MED	10.1038/nm.3773	512	51.2	8.734571
7	ALI HR, 2016, PLOS MED	10.1371/journal.pmed.1002194	381	42.3333333	6.44002181
8	HERVAS-STUBBS S, 2011, CLIN CANCER RES	10.1158/1078 − 0432.CCR-10-1114	352	25.1428571	5.54520548
9	LINES JL, 2014, CANCER RES	10.1158/0008-5472.CAN-13-1504	336	30.5454545	7.06542056
10	THEMELI M, 2013, NAT BIOTECHNOL	10.1038/nbt.2678	307	25.5833333	6.58886653
11	KORTYLEWSKI M, 2009, NAT BIOTECHNOL	10.1038/nbt.1564	301	18.8125	5.94746988
12	ZHOU GY, 2017, GASTROENTEROLOGY	10.1053/j.gastro.2017.06.017	293	36.625	7.12844365
13	MESSINA JL, 2012, SCI REP-UK	10.1038/srep00765	277	21.3076923	4.83894333
14	YUAN JD, 2008, P NATL ACAD SCI USA	10.1073/pnas.0810114105	269	15.8235294	6.88436019
15	HOLLERN DP, 2019, CELL	10.1016/j.cell.2019.10.028	260	43.3333333	6.31530705
16	DAS R, 2018, J CLIN INVEST	10.1172/JCI96798	254	36.2857143	5.72932331
17	DILILLO DJ, 2010, J IMMUNOL	10.4049/jimmunol.0903009	245	16.3333333	2.58257203
18	COPPOLA D, 2011, AM J PATHOL	10.1016/j.ajpath.2011.03.007	234	16.71428571	3.68630137
19	IKUTANI M, 2012, J IMMUNOL	10.4049/jimmunol.1101270	233	17.9230769	4.07030251
20	DURANTE MA, 2020, NAT COMMUN	10.1038/s41467-019-14256-1	227	45.4	4.984421